Cargando…

Efficacy and predictor of anti-TNFα agents in patients with intestinal Behçet's disease

BACKGROUND: Behçet’s disease (BD) is a recurrent multisystem inflammatory disease. Anti-tumor necrosis factor (TNF) α agents have been used to treat patients with intestinal BD with severe disease activity or those who are resistant to conventional treatments; however, the long-term efficacy of anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyazaki, Haruka, Watanabe, Daisuke, Okamoto, Norihiro, Tokunaga, Eri, Ku, Yuna, Takenaka, Haruka, Hoshi, Namiko, Ooi, Makoto, Kodama, Yuzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962253/ https://www.ncbi.nlm.nih.gov/pubmed/35346067 http://dx.doi.org/10.1186/s12876-022-02221-0

Ejemplares similares

Side Effects of COVID-19 Vaccines in Patients with Inflammatory Bowel Disease in Japan
por: Miyazaki, Haruka, et al.
Publicado: (2022)

Disseminated Mycobacterium avium Complex Infection in a Patient Treated With Immunosuppressants
por: Ito, Yuki, et al.
Publicado: (2023)

A case of autoimmune enteropathy with CTLA4 haploinsufficiency
por: Miyazaki, Haruka, et al.
Publicado: (2022)

LAT1 expression influences Paneth cell number and tumor development in Apc(Min/+) mice
por: Sui, Yunlong, et al.
Publicado: (2023)

Correction: LAT1 expression influences Paneth cell number and tumor development in Apc(Min/+) mice
por: Sui, Yunlong, et al.
Publicado: (2023)

Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
por: Miyazaki, Haruka, et al.
Publicado: (2023)

TNF and anti-TNF agents in Behçet's disease
por: Calamia, KT
Publicado: (2003)

Anti-TNF-α agents for refractory intestinal Behçet’s disease: case series and meta-analysis
por: Zhan, Shukai, et al.
Publicado: (2022)

Diagnosis and management of intestinal Behçet’s disease
por: Hisamatsu, Tadakazu, et al.
Publicado: (2014)

Feasibility of endoscopic submucosal dissection of lesions at anastomosis site post-colorectal surgery: a case series
por: Krutsri, Chonlada, et al.
Publicado: (2019)

Expression of TNF-α, April and BCMA in Behcet's Disease
por: Shaker, Olfat G., et al.
Publicado: (2014)

Intestinal Perforations in Behçet’s Disease
por: Chou, Shao-Jiun, et al.
Publicado: (2007)

Intestinal Behcet’s Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents
por: He, Kun, et al.
Publicado: (2023)

Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy
por: Caso, Francesco, et al.
Publicado: (2014)

W27 IgA suppresses growth of Escherichia in an in vitro model of the human intestinal microbiota
por: Sasaki, Kengo, et al.
Publicado: (2021)

Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease
por: Iwamoto, Junichi, et al.
Publicado: (2017)

Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease
por: Miyagawa, Ippei, et al.
Publicado: (2019)

Outcome Predictors for Intestinal Behçet's Disease
por: Park, Jae Jun, et al.
Publicado: (2013)

Tocilizumab-induced mucosal injury in the terminal ileum mimicking intestinal Behçet’s disease: A case report
por: Ozaka, Sotaro, et al.
Publicado: (2023)

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies
por: Hisamatsu, Tadakazu, et al.
Publicado: (2013)

The Efficacy of Medium- to Long-term Anti-TNF-α Antibody-based Maintenance Therapy in Behçet's Disease Patients with Intestinal Lesions
por: Kambayashi, Harutaka, et al.
Publicado: (2020)

Behçet's Disease with Bilateral Renal Infarction Due to Mucormycosis
por: Shimoyama, Kumiko, et al.
Publicado: (2021)

Acute Agitation as an Initial Manifestation of Neuro-Behçet's Disease
por: Otsuka, Yuki, et al.
Publicado: (2018)

Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
por: Fujiwara, Shun, et al.
Publicado: (2022)

Updated treatment strategies for intestinal Behçet’s disease
por: Park, Yong Eun, et al.
Publicado: (2018)

The treatment principles and targets for intestinal Behcet’s disease
por: He, Kun, et al.
Publicado: (2023)

Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet’s disease in Taiwan
por: Hu, Ya-Chiao, et al.
Publicado: (2019)

Pulmonary and intracranial miliary tuberculosis secondary to Behçet's anti-TNF alfa treatment
por: Sekkat, Asmae, et al.
Publicado: (2020)

Clinical heterogeneity of ocular Behçet’s syndrome versus intestinal Behçet’s syndrome: a cross-sectional study from Shanghai Behçet’s syndrome database
por: Hou, Cheng-cheng, et al.
Publicado: (2022)

Identification of genetic susceptibility loci for intestinal Behçet’s disease
por: Kim, Seung Won, et al.
Publicado: (2017)

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome
por: Zou, Jun, et al.
Publicado: (2022)

Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
por: Mori, Yuki, et al.
Publicado: (2020)

Canna starch improves immune functions and the intestinal environment in mice
por: TANAKA, Mamoru, et al.
Publicado: (2023)

Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study
por: Desbois, Anne Claire, et al.
Publicado: (2016)

Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease
por: Emmi, Giacomo, et al.
Publicado: (2016)

TNFα rs1800629 Polymorphism and Response to Anti-TNFα Treatment in Behçet Syndrome: Data from an Italian Cohort Study
por: Padula, Maria Carmela, et al.
Publicado: (2023)

A Case of Intestinal Behcet's Disease Similar to Crohn's Colitis
por: Kim, Eun-Sun, et al.
Publicado: (2007)

Intestinal Behçet's disease in a child--a case report.
por: Suh, Y. L., et al.
Publicado: (1987)

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease
por: Kaji, Mariko, et al.
Publicado: (2015)

The Role of Fecal Calprotectin in Evaluating Intestinal Involvement of Behçet's Disease
por: Özşeker, Burak, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_spdvk1pqavp1bugu0uqnsfea21